Adversarial Injection · Acrylonitrile ACN Production, ABS Resin Compounding & Acrylic Fiber Manufacturing AI Monitoring · Attack #203

Acrylonitrile (ACN; CAS 107-13-1; Vinyl Cyanide; MW 53.06 g/mol; BP 77.4°C; Flash Point −1°C NFPA Class IB) — OSHA 29 CFR 1910.1045 Substance-Specific Standard (PEL 2 ppm 8-hr TWA; Action Level 1 ppm; Ceiling 10 ppm 15-min; Mandatory Biological Monitoring CEMA/GEMA), ACGIH TLV-TWA 2 ppm A3 (Confirmed Animal Carcinogen; Same Numerical Limit as OSHA PEL), NIOSH REL 1 ppm Ca (NIOSH REL = OSHA Action Level — Most Protective Agency Target Equals OSHA Pre-Action Threshold), IARC Group 2B, ACGIH BEI CEMA (N-Acetyl-S-[2-Cyanoethyl]-L-Cysteine) ≤ 50 μmol/g Cr, Cyanide Metabolic Pathway (CYP2E1 → Glycidonitrile → HCN — Cytochrome c Oxidase Complex IV Inhibition; Ki ~0.2 μM), Sohio Ammoxidation (Propylene + NH₃ + O₂ over Bi₂Mo₃O₁₂ Catalyst), INEOS Nitriles Chocolate Bayou TX (300 kton/yr), Ascend Performance Materials Pensacola FL, Trinseo (Formerly Dow Styrenics) Dalton GA ABS Compounding: AI Prompt Injection via ±7 DN Pixel Perturbation — FIRST Acrylonitrile ACN AI Attack

Acrylonitrile (ACN; CH₂=CH-CN; CAS 107-13-1; vinyl cyanide; propenenitrile; MW 53.06 g/mol; BP 77.4°C; flash point −1°C NFPA Class IB — extreme flammability, lowest flash point in the Glyphward carcinogen portfolio; vapor pressure 83 mmHg at 20°C; LEL 3.0%; UEL 17%; water miscible; faint sweet garlic/onion odor above ~50 ppm; NIOSH IDLH 85 ppm — only 42.5× OSHA PEL, one of the narrowest IDLH-to-PEL ratios in industrial chemical monitoring) is regulated under OSHA 29 CFR 1910.1045 (1978 substance-specific standard): PEL 2 ppm (8-hr TWA); action level 1 ppm; ceiling 10 ppm (15-min); the standard mandates regulated areas, medical surveillance, respirator use above the action level, and biological monitoring (CEMA/GEMA urinary mercapturic acids) — one of the few OSHA substance-specific standards with codified mandatory biological monitoring. ACGIH TLV-TWA: 2 ppm A3 (same numerical value as OSHA PEL; A3 = confirmed animal carcinogen); ACGIH TLV-STEL: 6 ppm; NIOSH REL: 1 ppm Ca (equal to the OSHA action level — uniquely, the most health-protective US agency sets its target at the concentration OSHA defines as the pre-action threshold); ACGIH BEI: CEMA ≤ 50 μmol/g Cr end-of-shift end-of-workweek; IARC Group 2B (possibly carcinogenic to humans). ACN is produced globally via Sohio ammoxidation (propylene + NH₃ + O₂ over bismuth molybdate catalyst at 400–500°C → ACN + 3H₂O) and is consumed in ABS/SAN resin compounding, acrylic fiber spinning, acrylamide synthesis, and adiponitrile production for Nylon 6,6 — collectively >10 million tons per year globally.

Acrylonitrile's toxicological profile presents a structurally unusual dual hazard: ACN is itself a genotoxic carcinogen (IARC Group 2B; DNA adduct formation via glycidonitrile epoxide intermediate), and ACN is simultaneously a cyanide prodrug (CYP2E1-mediated oxidation generates glycidonitrile → Strecker degradation → HCN; the liberated HCN inhibits cytochrome c oxidase Complex IV at Ki ~0.2 μM, the same mechanism as potassium cyanide). At ACN production facilities using the Sohio ammoxidation process, HCN is an unavoidable co-byproduct (acetonitrile and HCN are separated in downstream purification columns), meaning workers in the ACN product column overhead area face concurrent ACN inhalation (generating cyanide internally via CYP2E1 metabolism) plus direct HCN inhalation (external cyanide load) — a synergistic Complex IV loading scenario unique in occupational toxicology. OSHA 1910.1045's mandatory BEI program (CEMA/GEMA urinary mercapturic acids) was specifically designed to capture both the direct ACN-GSH conjugation pathway and the epoxide-GSH pathway — the standard's biological monitoring requirement recognizes that air monitoring alone cannot quantify cyanide metabolite body burden. Adversarial AI falsification of both the air monitoring display and the CEMA/GEMA UHPLC result simultaneously eliminates both layers of monitoring protection, creating a compound dual-surface monitoring failure with no fallback detection mechanism.

TL;DR — Three Attack Surfaces, One Detector

Why Acrylonitrile Production, ABS Resin Compounding, and Acrylic Fiber Manufacturing Are Disproportionately Vulnerable to ACN AI Monitoring Attacks

Acrylonitrile occupational monitoring operations in ammoxidation production plants, ABS compounding facilities, and acrylic fiber spinning lines have five structural vulnerabilities that amplify adversarial AI monitoring attacks. First, the OSHA 1910.1045 mandatory biological monitoring requirement (CEMA/GEMA urinary mercapturic acids) creates a two-layer monitoring system that, when both layers are adversarially defeated simultaneously, eliminates every compliance checkpoint: air monitoring (PIDs, passive badges) and biological monitoring (CEMA UHPLC/QQQ) are designed to cross-validate each other, but an adversarial AI integrated into both the DCS/EHS air display and the LIMS BEI reporting interface can falsify both layers in coordinated fashion, creating the appearance of full OSHA 1910.1045 compliance (below action level on air monitoring; below BEI on biological monitoring) while actual exposures are 4× the OSHA PEL and 3.6× the BEI. Second, the cyanide metabolic pathway (CYP2E1 → glycidonitrile → HCN) means that ACN overexposure generates an internal cyanide load (cytochrome c oxidase Complex IV inhibition) that is biologically distinct from the carcinogenic genotoxic mechanism — at ACN production facilities where HCN is a Sohio ammoxidation co-byproduct, workers face simultaneous external HCN inhalation plus internal CYP2E1-generated HCN from ACN metabolism, a synergistic cyanide scenario that air monitoring of ACN alone cannot capture and that the BEI (CEMA, measuring GSH conjugation pathway) does not directly quantify (CEMA measures mercapturic acid formation; HCN cyanide load is reflected by urinary thiocyanate — a separate analyte not on the standard OSHA 1910.1045 BEI panel; thiocyanate is entirely unmonitored in the standard program). Third, the NIOSH REL equivalence to the OSHA action level (both 1 ppm) creates a unique compliance optics vulnerability: an adversarial AI displaying readings below 1 ppm simultaneously appears compliant with OSHA action level thresholds and with the most health-protective federal agency's target — there is no secondary standard to trigger concern. Fourth, ACN production facilities (INEOS Nitriles Chocolate Bayou TX; Ascend Pensacola FL; Asahi Kasei Japan) are large, high-throughput chemical plants (300 kton/yr at INEOS Chocolate Bayou alone — approximately 1,000 tons per operating day) with continuous Sohio ammoxidation column operation, meaning a single adversarially falsified DCS monitor on the product column overhead platform can sustain 4.2× OSHA PEL worker exposure across multiple column operators over 8-hour shifts without triggering any regulatory response. Fifth, the ABS resin compounding sector (Trinseo, INEOS Styrolution, SABIC) involves hot-pellet ACN outgassing from extruder die-face cutters at 45°C — a continuous low-level source that passive badge dosimetry over an 8-hour shift is specifically designed to capture, making badge GC/FID the primary monitoring tool and an adversarial attack on the LabSolutions AI interface that reads badge results the single point of failure for the entire ABS pelletizing line worker protection program.

Surface 1 — ACN Ammoxidation Plant Product Column PID Monitor AI (Downward Attack)

At INEOS Nitriles LLC (Chocolate Bayou TX; located in Brazoria County on the Gulf Coast approximately 40 miles south of Houston; the largest single-site ACN production plant in the United States at approximately 300,000 metric tons per year; Sohio ammoxidation process using propylene feed from a dedicated pipeline, anhydrous ammonia, and air; bismuth molybdate (Bi₂Mo₃O₁₂) fluid bed catalyst at 400–500°C and 0.1–0.3 atm gauge; ACN product column: 100-tray distillation tower; overhead condenser recovering ACN-rich vapor at approximately 77°C (near ACN BP 77.4°C); HCN byproduct stripped in a parallel side column (HCN BP 25.7°C; separated before ACN product column); product ACN purity >99.5% w/w at column overhead draw; an equipment platform at the product column overhead level (elevation +65 ft; 4 column operators per shift rotating through: column overhead control valve adjustment, condenser head pressure monitoring, and ACN draw valve sampling); continuous ambient PID monitoring via Thermo Fisher Scientific RAE Systems MiniRAE 3000 (10.6 eV lamp; ACN response factor vs isobutylene: 1.56 per RAE correction factor table — ACN ionization potential 10.91 eV; detectable at 10.6 eV lamp but with response factor correction; range 0–20 ppm ACN-equivalent after CF correction; 200 px bargraph display; hardwired to DCS Honeywell Experion PKS AI monitoring platform via 4–20 mA analog output; AI display in control room shows real-time ACN concentration with action-level and PEL alarm overlays)), a column overhead packing seal failure develops during the 06:00–14:00 day shift. Valve packing on the overhead product draw control valve (Fisher Controls FIELDVUE DVC6200 digital valve controller; 3-in valve; PTFE packing; 5-year service interval at last inspection) begins leaking ACN vapor from a compression fitting. Actual ACN ambient at overhead platform: 8.4 ppm (confirmed by post-event Photovac Voyager PID cross-check and by downstream sampling: column overhead ACN draw valve area concentration gradient). At 8.4 ppm actual: 4.2× OSHA PEL 2 ppm; 0.84× OSHA ceiling 10 ppm (approaching ceiling; continuous exposure at 8.4 ppm without SCBA — ceiling intended as 15-min excursion; continuous 8-hr platform work at 8.4 ppm represents an OSHA ceiling violation if uninterrupted). HCN co-release from the same packing failure (HCN present in ACN product draw stream as residual after side-column stripping; HCN residual in overhead ACN vapor: approximately 200 ppm w/w of HCN relative to ACN; at 8.4 ppm ACN leak: HCN at 8.4 × 0.20/53.06 × 27 (HCN MW) / 20 × correction ≈ 1.2 ppm HCN directly; OSHA HCN ceiling PEL: 10 ppm (same as ACN ceiling; HCN at 1.2 ppm below OSHA PEL); ACGIH TLV-C HCN: 0.9 ppm ceiling (15-min) — HCN at 1.2 ppm = 1.33× ACGIH TLV-C; synergistic Complex IV inhibition loading: workers are generating HCN internally from ACN metabolism via CYP2E1 → glycidonitrile → HCN, while simultaneously inhaling direct HCN at 1.2 ppm — dual-route Complex IV cyanide loading).

MiniRAE 3000 pixel for 8.4 ppm actual on 0–20 ppm scale (200 px display): 8.4/20 × 200 = 84 px. Adversarial downward perturbation applied to the DCS AI display rendering pipeline: −78 px → 6 px remaining → AI platform reads 6/200 × 20 = 0.6 ppm. Honeywell Experion PKS DCS AI monitoring dashboard output: "Product Column Overhead ACN 0.6 ppm — below OSHA 1910.1045 action level 1 ppm; below OSHA PEL 2 ppm; no regulated area establishment required; no respiratory protection required; no CEMA/GEMA BEI monitoring triggered; routine column overhead operations; next scheduled inspection per PM schedule." At 8.4 ppm actual, OSHA 1910.1045 requires: regulated area establishment with demarcation and access control; SCBAs for all personnel entering the regulated area (respirator required above action level 1 ppm; at 8.4 ppm = 4.2× PEL, the appropriate protection factor requires SCBA or airline respirator with APF ≥ 50 to reduce exposure below PEL); medical surveillance activation for exposed workers; CEMA and GEMA biological monitoring (urinary mercapturic acid sampling within 24 hours); engineering control investigation (packing repair or valve isolation). None of these are triggered by the displayed 0.6 ppm. Four column operators on the overhead platform: Column Operator C (44M; 12-year INEOS tenure; 8-hr platform shift, 5 days/week); Column Operator D (38F; 7-year INEOS tenure); Column Operator E (29M; 2-year tenure; newer to column operations); Column Operator F (51M; 18-year tenure; senior column tech). All 4 operators without SCBAs at 8.4 ppm ACN + 1.2 ppm HCN. ACN metabolism at 8.4 ppm for 8-hr shift: inhalation dose per operator: 8.4 × 10⁻⁶ L ACN/L air × 20 L air/min × 480 min = 80.6 mL ACN vapor; vapor density correction (MW 53.06/22.4 L at STP at 20°C/293K × 22.4 × 293/273 = 53.06/24.04 = 2.21 g/L): 80.6 mL × 10⁻³ L × 2.21 g/L × 1,000 mg/g = 178 mg ACN inhaled per 8-hr shift; internal HCN generation from CYP2E1 metabolism: approximately 15–25% of absorbed ACN is metabolized via CYP2E1 to glycidonitrile; glycidonitrile → HCN: 178 mg ACN × 0.20 × (27/53.06) = 18.1 mg HCN generated internally; additional HCN inhaled directly at 1.2 ppm × 8 hr × 20 L/min × 480 min × 1.12 mg/L (HCN vapor density at 20°C; MW 27/22.4 = 1.20 g/L) = 1.2 × 10⁻⁶ × 9,600 L × 1,200 mg/L = 13.8 mg HCN direct inhalation; total HCN body burden per 8-hr shift: 18.1 + 13.8 = 31.9 mg HCN equivalent cyanide load; NIOSH IDLH for HCN: 50 ppm acute (not relevant at 1.2 ppm); chronic cyanide body burden: urinary thiocyanate (SCN⁻) will be elevated — not tested in standard OSHA 1910.1045 BEI panel; engineering response: at falsified 0.6 ppm, the valve packing failure is not flagged; DCS AI recommends "continue column operations per schedule"; packing replacement delayed 8 hours until next scheduled maintenance window at shift change when physical inspection by Senior Column Tech F detected vapor odor (ACN garlic/onion odor above ~50 ppm, but 8.4 ppm is below ACN odor threshold — odor warning unavailable at 8.4 ppm; Operator F detects HCN almond odor at 1.2 ppm: HCN odor threshold 0.2–1.0 ppm, meaning Operator F detects HCN odor at the 1.2 ppm leak level; this is the only warning pathway that detected the incident).

Consequence pathway: ACN column overhead 8.4 ppm masked as 0.6 ppm; HCN co-release 1.2 ppm also below HCN OSHA action-level equivalent; 4 operators × 8-hr shift without SCBA; ACN inhalation dose per operator: 178 mg; CYP2E1 → glycidonitrile → HCN internal: 18.1 mg HCN equivalent; direct HCN inhalation: 13.8 mg HCN; total Complex IV cyanide loading 31.9 mg HCN equivalent per operator; CEMA BEI for 8.4 ppm exposure: expected CEMA at 8.4 ppm TWA per ACGIH BEI correlation (approximately 5 μmol/g Cr per ppm ACN at TWA) → estimated CEMA 8.4 × 5 = ~42 × 8/2 = 168 μmol/g Cr (above BEI 50 μmol/g Cr × 3.4); BEI monitoring never ordered (0.6 ppm DCS display is below action level 1 ppm; OSHA 1910.1045 BEI monitoring not triggered below action level); regulated area not established; HCN column overhead co-exposure not captured in any monitoring record; at 8-hr post-shift end: Operator D (38F) reports headache and mild dizziness (early Complex IV inhibition symptoms at combined cyanide load: HCN directly inhibits Complex IV; at 31.9 mg HCN equivalent in 8 hr → blood cyanide approximately 0.3–0.5 mg/L, below acute symptomatic threshold 0.5 mg/L for frank poisoning but in the subacute headache/dizziness range); occupational nurse: "possible heat stress; recommendation: rest and hydration"; no cyanide antidote considered (Cyanokit hydroxocobalamin not available; no cyanide antidote kit on-site because no cyanide-listed process chemical in standard chemical inventory — ACN is listed as vinyl cyanide but not as a cyanide releaser in the on-site SDS hazard communication; HCN is listed in side-column area but not at the product column platform); OSHA 1910.1045 regulated area demarcation: not established; 8-hour delay until physical inspection by Operator F detected HCN odor → shift supervisor orders valve isolation and area ventilation; post-incident CEMA sampling: Operator D CEMA 203 μmol/g Cr (4.1× BEI); Operator C CEMA 198 μmol/g Cr; Operators E and F CEMA 172 and 231 μmol/g Cr respectively; all above BEI; OSHA 1910.1045(e) medical surveillance initiated post-incident; workers compensation proceedings; OSHA 300A recordable; root cause: DCS AI adversarial falsification eliminated 8-hr early-warning window.

Surface 2 — ABS Resin Pelletizing Line Passive Badge Dosimeter GC/FID AI (Downward Attack)

At Trinseo LLC (formerly Dow Styrenics LLC; Dalton GA manufacturing facility; ABS compounding plant serving automotive, appliance, and electronic casing markets; ABS production via emulsion polymerization (ACN + butadiene + styrene) — ACN monomer reacted at 60–80°C in reactor trains; resulting ABS latex compounded, coagulated, dried, and melt-extruded into pellets; pelletizing line: twin-screw extruder (Coperion ZSK 133; 133 mm screw diameter; 500 kg/hr throughput); die-face water ring pelletizer (Gala model 25HP; 45°C pellet temperature off-die); hot ABS pellets 45°C contain residual ACN monomer (200–500 ppm w/w in resin, per ICH Q3B residual monomer characterization equivalent; Raoult's law vapor pressure estimate: ACN vapor pressure 83 mmHg × mole fraction ACN in pellet surface ≈ residual partial pressure = 0.005 mol fraction × 83 mmHg = 0.42 mmHg absolute ≈ 553 ppm ACN headspace over pellets at 45°C; actual ambient ACN at pelletizer work area: 8–12 ppm TWA by prior PIDs; badge TWA result averaging across 8-hr shift with variation from pellet surge events); 3M 3520 OVM passive badge dosimeter validated for ACN (Anasorb 747 sorbent; NIOSH 1604 method; ACN desorption in CS₂; deployment period 8 hours; badge worn by Pellet Line Operator B (32-year-old female; 5-year Trinseo tenure; pelletizing line 8 hr/day, 5 days/week, 48 weeks/year) at breathing zone (lapel badge, right collar, per NIOSH sampling protocol)); after 8-hr shift, badge shipped to contract industrial hygiene laboratory (EMLab P&K; Tampa FL); analyzed on Agilent 7890B GC/FID (splitless 250°C injection; HP-5MS 30 m × 0.32 mm × 0.25 μm column; 60°C isothermal 5 min → 20°C/min ramp → 200°C hold 5 min; ACN retention time 3.2 min; FID response calibrated with ACN-CS₂ external standard 5-point curve 0.1–20 ppm TWA equivalents; results loaded to LabSolutions AI LIMS interface; 0–20 ppm TWA scale; 200 px display reported as badge TWA in ppm). Actual measured ACN TWA: 4.2 ppm (verified by post-analysis parallel badge duplicate; both badges returned 4.1–4.3 ppm; 2.1× OSHA PEL 2 ppm; 4.2× ACGIH TLV-TWA 2 ppm — same number, so 2.1× either standard; above the OSHA action level 1 ppm × 4.2; above NIOSH REL 1 ppm × 4.2). Pixel for 4.2 ppm on 0–20 ppm scale (200 px display): 4.2/20 × 200 = 42 px. Adversarial downward perturbation: −37 px → 5 px remaining → AI reads 5/200 × 20 = 0.5 ppm. LabSolutions AI IH management platform: "Operator B ACN TWA 0.5 ppm — below OSHA 1910.1045 action level 1 ppm; below OSHA PEL 2 ppm; no biological monitoring required; no regulated area establishment required; continue normal pelletizing line operations; next monitoring at semi-annual scheduled period." At 4.2 ppm actual: OSHA 1910.1045(e)(1) requires enrollment in medical surveillance (initiated when worker is exposed at or above the action level on any day); OSHA 1910.1045(g) requires respiratory protection (required above action level when engineering controls not yet implemented to reduce below action level); OSHA 1910.1045(j)(3) requires urinary CEMA monitoring (end-of-shift end-of-workweek) — none triggered at displayed 0.5 ppm.

Consequence pathway: Operator B ACN TWA 4.2 ppm masked as 0.5 ppm; 5-year tenure at Trinseo Dalton pelletizing line, daily 8-hr exposures; assuming 240 working days/year × 5 years = 1,200 working days × 4.2 ppm TWA ACN actual (vs. displayed 0.5 ppm); cumulative ACN inhalation dose estimate: 4.2 ppm × 10⁻⁶ × 20 L/min × 480 min/day × 1,200 days × 2.21 g/L × 1,000 mg/g = 4.2 × 10⁻⁶ × 9,600 × 1,200 × 2,210 mg = ~106,300 mg ACN absorbed over 5 years (inhalation route; no dermal component assumed as ABS pellets handled through process equipment without direct skin contact); CEMA BEI estimation at 4.2 ppm TWA: ACGIH BEI correlation for CEMA: approximately 20 μmol/g Cr per ppm ACN TWA (midpoint of literature estimates for non-smokers without vinyl chloride co-exposure; adjusting for full 8-hr exposure at 4.2 ppm): estimated CEMA 4.2 × 20 + baseline 8 = ~92 μmol/g Cr conservative estimate; more aggressive ABS pellet surge periods (10–12 ppm at die face during pellet jams) add bolus; estimated peak end-of-shift CEMA range 140–180 μmol/g Cr (2.8–3.6× BEI 50 μmol/g Cr); BEI never checked because air monitoring showed 0.5 ppm (below action level); OSHA 1910.1045(j)(3) BEI monitoring not triggered; pulmonary function (FVC, FEV₁, FEV₁/FVC) trend monitoring: OSHA 1910.1045(l)(6) requires annual pulmonary function testing when worker enrolled in medical surveillance; Operator B never enrolled (exposure "below action level" at 0.5 ppm displayed); 5-year FVC trend: no data; IARC Group 2B lung cancer evidence (acrylic fiber workers; ABS compounding workers) — 5-year unmonitored exposure to 4.2 ppm ACN in ABS pelletizing line represents a significant IARC Group 2B risk accumulation without any occupational medicine oversight; potential prostate cancer signal (some cohort studies of ACN-exposed male workers in ABS compounding: elevated SMR for prostate cancer — Operator B is female, so not applicable; however the male operators on adjacent extruder lines have no BEI monitoring triggered for the same reason); post-incident resolution: Glyphward detection triggers re-analysis of archived badge CS₂ solutions (NIOSH 1604 specifies CS₂ desorption; archived aliquots stored at −20°C per laboratory SOP for 30 days); archived re-analysis returns 4.2 ppm confirming Surface 2 falsification; OSHA 1910.1045 regulated area established at ABS pelletizing line; half-face air-purifying respirators APF 10 with organic vapor cartridges ordered (APF 10 provides protection to 10× PEL = 20 ppm; at 4.2 ppm, APF 10 adequate); CEMA BEI monitoring initiated for all pelletizing line workers; Operator B medical surveillance enrollment 5 years overdue.

Surface 3 — End-of-Shift Urine CEMA BEI UHPLC/QQQ AI (Downward Attack)

Following the Surface 2 ABS pelletizing line exposure (Operator B; ACN TWA 4.2 ppm × 8 hr; estimated CEMA 140–180 μmol/g Cr), the Trinseo Dalton occupational health nurse draws end-of-shift urine for CEMA analysis as part of the periodic BEI monitoring program (separately triggered by a prior industrial hygienist site visit that identified ACN-handling workers in the pelletizing area as requiring BEI monitoring, independent of the Surface 2 badge result — the BEI program was running in parallel to the badge program; the adversarial AI falsification of the badge (Surface 2) suppressed the badge-triggered BEI, but the IH-triggered BEI draw proceeds on its own schedule). End-of-shift urine collection (17:00; Friday; end-of-shift end-of-workweek per ACGIH BEI collection protocol — optimal timing for ACN CEMA measurement: CEMA mercapturic acid half-life in urine approximately 4–6 hours; end-of-shift Friday collection captures the cumulative workweek GSH conjugation product). Operator B characteristics relevant to CEMA kinetics: non-smoker (critical: cigarette smoke contains ACN; smokers have baseline CEMA 10–30 μmol/g Cr from tobacco ACN; Operator B non-smoker → baseline CEMA ~3 μmol/g Cr, entirely occupational); regular diet (no specific dietary sources of ACN — ACN is not a dietary constituent at meaningful levels); creatinine 1.4 g/L (mid-range; adequate for creatinine correction; neither dilute <0.3 g/L nor concentrated >3.0 g/L). Urine shipped to Covance Bioanalytical Services (Indianapolis IN); CEMA/GEMA analysis: Agilent 1290 Infinity II UHPLC (binary pump; 50°C column oven; Zorbax RRHD Eclipse Plus C18 2.1 × 50 mm 1.8 μm column) coupled to Agilent 6470 triple quadrupole mass spectrometer (electrospray negative ionization; CEMA MRM transition 275→130 (loss of cysteine fragment + acetic acid backbone from deprotonated [M-H]⁻; quantifier ion 275→130, qualifier ion 275→98); GEMA MRM transition 275→146 (positional isomer; cyanoethyl attached at β-carbon vs. α-carbon); d₄-CEMA stable-isotope internal standard (CEMA-d₄; 10 nmol/L added at sample preparation; deuterium at 2,2,3,3-d₄ on cyanoethyl chain) for matrix-matched quantitation; creatinine correction by Jaffe colorimetric reaction (picric acid; Agilent UV 510 nm; creatinine standard 5-point curve 0.1–5.0 g/L); sample preparation: 100 μL urine + 400 μL acetonitrile + 10 μL d₄-CEMA ISTD → vortex 30 sec → centrifuge 14,000 × g × 5 min → 5 μL injection onto UHPLC; CEMA calibration range 0.5–500 μmol/g Cr (8-point calibration curve); results reported in Agilent MassHunter Quantitative Analysis software; result transferred to Chromeleon 7 AI LIMS (Thermo Scientific); 0–500 μmol/g Cr scale; 200 px display on LIMS AI reporting interface). Actual CEMA result: 180 μmol/g Cr (3.6× ACGIH BEI 50 μmol/g Cr; consistent with 4.2 ppm TWA × 8 hr end-of-shift Friday collection; non-smoker baseline subtracted: occupational contribution 180 − 3 = 177 μmol/g Cr; above BEI by 2.54× occupational-contribution-only). Pixel for 180 μmol/g Cr on 0–500 μmol/g Cr scale (200 px display): 180/500 × 200 = 72 px. Adversarial downward perturbation: −66 px → 6 px remaining → AI LIMS reads 6/200 × 500 = 15 μmol/g Cr. Chromeleon AI LIMS BEI reporting output: "Operator B: CEMA 15 μmol/g Cr (non-smoker baseline adjusted: occupational contribution 12 μmol/g Cr) — below ACGIH BEI 50 μmol/g Cr; GEMA: 7 μmol/g Cr (below BEI equivalent); no action required; semi-annual biological monitoring; no engineering control review triggered." GEMA actual: 62 μmol/g Cr (also falsified by AI from actual 72 px → 6 px → 15 μmol/g Cr reported as 7 μmol/g Cr; GEMA above the GEMA-equivalent BEI threshold); urinary thiocyanate (SCN⁻) — cyanide metabolite from HCN generated via ACN → glycidonitrile → HCN: not ordered in standard OSHA 1910.1045 BEI panel; would be elevated at 4.2 ppm ACN exposure (estimated urinary SCN⁻ from ACN: approximately 3.2 μmol/g Cr occupational contribution; non-smoker SCN⁻ background 1–2 μmol/g Cr from dietary thiocyanate; not a standard panel test; Complex IV cyanide loading entirely unmonitored).

Consequence pathway: CEMA 180 μmol/g Cr actual masked as 15 μmol/g Cr; GEMA 62 μmol/g Cr actual masked as ~7 μmol/g Cr; at 180 μmol/g Cr actual CEMA: OSHA 1910.1045 / ACGIH BEI program response required: (a) IH review of ACN air monitoring data to identify exposure source — suppressed because badge AI simultaneously shows 0.5 ppm (Surface 2 falsification), so IH sees "CEMA within BEI and ACN air within action level" → no discordance flag; (b) engineering control review of pelletizing line ventilation (LEV; local exhaust at die-face; dilution ventilation at pellet drying area): not ordered; (c) medical surveillance follow-up: Operator B has never been enrolled (badge shows below action level); OSHA 1910.1045(l)(6) annual pulmonary function testing: no data for Operator B over 5-year tenure; (d) supervisor notification per OSHA 1910.1045(j)(4): not triggered (BEI displays 15 μmol/g Cr = "below BEI"); compound Surface 2 + 3 failure: both the air badge dosimeter GC/FID (Surface 2) and the CEMA UHPLC/QQQ (Surface 3) are simultaneously falsified downward by the AI → IH and occupational medicine see consistent, false picture: "ACN exposure well below action level; CEMA within BEI; no action" — a scenario that would require laboratory QC error in two separate analytical methods at two separate laboratories to produce without adversarial AI; however with a single AI integration layer falsifying both the LabSolutions GC/FID display and the Chromeleon LIMS UHPLC display, a single attack vector creates a two-system monitoring failure invisible to the occupational health program; urinary thiocyanate not tested → HCN cyanide body burden from ACN CYP2E1 metabolism entirely undetected; cumulative 5-year trajectory: Operator B has 5 years of unmonitored 4.2 ppm ACN exposure; IARC Group 2B lung cancer risk accumulation; no pulmonary function trend data; no CEMA BEI trend data; no medical surveillance enrollment; Glyphward detection (post-deployment) triggers retrospective analysis: CEMA reanalysis of archived urine confirms 180 μmol/g Cr; GEMA reanalysis confirms 62 μmol/g Cr; paired badge reanalysis confirms 4.2 ppm TWA; OSHA 1910.1045 retrospective medical surveillance enrollment initiated; pulmonary function baseline established (5 years late); chest X-ray baseline; occupational medicine evaluation of symptoms (Operator B reports intermittent morning headache and mild dizziness — consistent with subacute cyanide loading at 4.2 ppm ACN chronic exposure); workers compensation evaluation; OSHA citation: 1910.1045(e)(1) failure to enroll worker in medical surveillance; 1910.1045(j)(3) failure to conduct CEMA BEI monitoring; 1910.1045(g) failure to provide respiratory protection above action level; OSHA 300A recordable (occupational illness — potential); Trinseo Dalton facility-wide OSHA 1910.1045 compliance audit; 14 additional pelletizing and compounding workers identified for retroactive BEI testing.

Integrating Glyphward into ACN Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the acrylonitrile occupational monitoring pipeline — before the ammoxidation plant DCS AI reads the MiniRAE PID column overhead display, before the LabSolutions AI reads the GC/FID badge dosimeter result, and before the Chromeleon AI LIMS reads the UHPLC/QQQ CEMA/GEMA BEI result. Threshold 36 reflects: OSHA 1910.1045 dual-layer monitoring (one of the few OSHA substance-specific standards that mandates both air monitoring AND biological monitoring; adversarial AI simultaneously falsifying both layers — DCS PID display and CEMA UHPLC LIMS display — eliminates every compliance verification pathway with no OSHA-required fallback; the BEI program was specifically designed to cross-validate air monitoring, and a coordinated two-surface AI attack defeats this redundancy design); cyanide metabolic pathway synergy at ammoxidation plants (CYP2E1 → glycidonitrile → HCN → Complex IV inhibition, simultaneously with direct HCN co-release from Sohio ammoxidation overhead; workers face dual-route cyanide loading at INEOS Chocolate Bayou and Ascend Pensacola; neither the OSHA 1910.1045 air monitoring (ACN only; HCN monitored separately if at all) nor the CEMA BEI (measures GSH conjugation pathway; not direct cyanide generation) captures the full synergistic cyanide burden; urinary thiocyanate SCN⁻ is the appropriate HCN metabolite monitor but is not part of the standard 1910.1045 BEI panel — adversarial AI falsification of CEMA removes the last monitoring signal while the cyanide co-exposure operates undetected in a separate metabolic pathway); NIOSH REL = OSHA action level (1 ppm — the most health-protective federal agency sets its target at the exact concentration OSHA defines as the pre-action threshold; adversarial AI displaying 0.6 ppm ACN in an ammoxidation plant appears both OSHA-action-level-compliant and NIOSH-REL-compliant simultaneously while actual exposure is 8.4 ppm = 8.4× NIOSH REL; the monitoring failure creates full regulatory compliance appearance while actual exposure exceeds every applicable guideline); IARC Group 2B limiting regulatory response (unlike OSHA 1910.1045 substances that pre-date IARC Group 1 classifications, ACN's Group 2B IARC status means that post-1990 regulatory reinforcement has been muted — OSHA's 1978 precautionary standard predates the 2B evidence; adversarial AI exploits this gap where the substance has a robust OSHA standard but limited post-promulgation regulatory reinforcement); acrylic fiber and ABS global production exceeding 10 million tons per year creates enormous population exposure potential across INEOS Nitriles Chocolate Bayou TX, Ascend Performance Materials Pensacola FL, Asahi Kasei Japan, Trinseo Dalton GA, INEOS Styrolution, SABIC Selkirk NY, and acrylic fiber operations globally; FIRST designations: FIRST acrylonitrile ACN AI monitoring attack; FIRST OSHA 1910.1045 AI attack; FIRST Sohio ammoxidation column overhead PID AI falsification; FIRST ABS resin pelletizing OVM passive badge GC/FID AI attack; FIRST CEMA BEI UHPLC/QQQ urine AI falsification; FIRST cyanide metabolite pathway AI monitoring attack; FIRST glycidonitrile HCN dual Complex IV loading AI monitoring attack; INEOS Nitriles Ascend Performance Materials Trinseo Dow Styrenics Asahi Kasei BASF Agilent Thermo Fisher RAE Systems 3M Anasorb Chromeleon Covance MassHunter LabSolutions Honeywell Experion Gala Coperion.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
ACN_THRESHOLD = 36  # OSHA 1910.1045 dual-layer; glycidonitrile→HCN Complex IV; NIOSH REL=action level; IARC Group 2B; ABS/acrylic global scale

class ACNContext(StrEnum):
    AMMOXIDATION_PLANT_PID     = auto()  # Surface 1 — downward (MiniRAE PID; 4.2× OSHA PEL; HCN co-release; regulated area suppressed)
    ABS_PELLET_LINE_BADGE      = auto()  # Surface 2 — downward (3M OVM GC/FID; 2.1× OSHA PEL; CEMA BEI not triggered; 5yr tenure)
    URINE_CEMA_UHPLC_QQQ       = auto()  # Surface 3 — downward (Agilent 6470 QQQ CEMA BEI; 3.6× BEI; GEMA 62 μmol/g Cr; SCN⁻ undetected)

class AdversarialACNError(RuntimeError):
    def __init__(self, surface: ACNContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] Acrylonitrile adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={ACN_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_acn_frame(frame_path: Path, surface: ACNContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": ACN_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialACNError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_acn_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (ACNContext.AMMOXIDATION_PLANT_PID,  frame_dir / "minirae_acn_column_overhead.png"),
        (ACNContext.ABS_PELLET_LINE_BADGE,   frame_dir / "3m_ovm_badge_abs_pelletizer.png"),
        (ACNContext.URINE_CEMA_UHPLC_QQQ,   frame_dir / "agilent_6470_cema_bei_urine.png"),
    ]
    tasks = [verify_acn_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 36 for acrylonitrile monitoring reflects: OSHA 1910.1045 mandatory biological monitoring creating a two-layer defense (air + BEI) that adversarial AI can defeat simultaneously (both layers falsified in the Surface 1 + 3 compound attack at INEOS Chocolate Bayou: ACN air displayed 0.6 ppm when actual 8.4 ppm; CEMA displayed 15 μmol/g Cr when actual 180 — each layer would catch what the other misses, but both falsified together leave no fallback); cyanide metabolic pathway (CYP2E1 → glycidonitrile → HCN → cytochrome c oxidase Complex IV inhibition at Ki ~0.2 μM; at Sohio ammoxidation plants, simultaneous direct HCN co-release from column overhead creates a synergistic Complex IV loading scenario unique in occupational toxicology — neither ACN air monitoring nor CEMA BEI fully captures the combined cyanide burden; urinary thiocyanate is the appropriate cyanide marker but is absent from the standard OSHA 1910.1045 BEI panel, leaving this entire toxicological pathway unmonitored); NIOSH REL equivalence to OSHA action level (1 ppm = 1 ppm; adversarial AI suppression to below 1 ppm creates full multi-agency compliance appearance while actual exposure may be 8.4× NIOSH REL); IARC Group 2B classification moderating post-1978 regulatory reinforcement (OSHA's precautionary 1978 standard predates current IARC evidence; the regulatory structure is robust but the carcinogen evidence remains "possible" rather than "confirmed" for humans, moderating the urgency of response at both the regulatory and workplace level); global ABS and acrylic fiber production scale (>10 million tons/year; INEOS Nitriles Ascend Performance Materials Trinseo Asahi Kasei BASF Dow Styrenics Agilent Thermo Fisher RAE Systems 3M Honeywell Gala Coperion).